GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lumos Diagnostics Holdings Ltd (OTCPK:LDXHF) » Definitions » Equity-to-Asset

Lumos Diagnostics Holdings (Lumos Diagnostics Holdings) Equity-to-Asset : 0.40 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Lumos Diagnostics Holdings Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Lumos Diagnostics Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $9.23 Mil. Lumos Diagnostics Holdings's Total Assets for the quarter that ended in Dec. 2023 was $23.05 Mil. Therefore, Lumos Diagnostics Holdings's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.40.

The historical rank and industry rank for Lumos Diagnostics Holdings's Equity-to-Asset or its related term are showing as below:

LDXHF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.37   Med: 0.46   Max: 0.86
Current: 0.4

During the past 2 years, the highest Equity to Asset Ratio of Lumos Diagnostics Holdings was 0.86. The lowest was 0.37. And the median was 0.46.

LDXHF's Equity-to-Asset is ranked worse than
73.08% of 234 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.59 vs LDXHF: 0.40

Lumos Diagnostics Holdings Equity-to-Asset Historical Data

The historical data trend for Lumos Diagnostics Holdings's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumos Diagnostics Holdings Equity-to-Asset Chart

Lumos Diagnostics Holdings Annual Data
Trend Jun22 Jun23
Equity-to-Asset
0.48 0.37

Lumos Diagnostics Holdings Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial 0.72 0.48 0.44 0.37 0.40

Competitive Comparison of Lumos Diagnostics Holdings's Equity-to-Asset

For the Diagnostics & Research subindustry, Lumos Diagnostics Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lumos Diagnostics Holdings's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lumos Diagnostics Holdings's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Lumos Diagnostics Holdings's Equity-to-Asset falls into.



Lumos Diagnostics Holdings Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Lumos Diagnostics Holdings's Equity to Asset Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Equity to Asset (A: Jun. 2023 )=Total Stockholders Equity/Total Assets
=9.498/25.419
=0.37

Lumos Diagnostics Holdings's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=9.227/23.052
=0.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lumos Diagnostics Holdings  (OTCPK:LDXHF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Lumos Diagnostics Holdings Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Lumos Diagnostics Holdings's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Lumos Diagnostics Holdings (Lumos Diagnostics Holdings) Business Description

Traded in Other Exchanges
Address
2724 Loker Ave West, Carlsbad, CA, USA, 92010
Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. It also directly develops, manufactures and commercializes proprietary, Lumos-branded POC tests that target infectious and inflammatory diseases. It generates maximum revenue from the commercial services and solutions relating to POC diagnostic tests.

Lumos Diagnostics Holdings (Lumos Diagnostics Holdings) Headlines